Beyond Checkpoint Inhibition: New Therapeutic Approaches to Bladder Cancer
Dr. Daniel P. Petrylak presented “Beyond Checkpoint Inhibition: New Therapeutic Approaches...
Read MoreSelect Page
Posted by Daniel P. Petrylak, MD | May 2017
Dr. Daniel P. Petrylak presented “Beyond Checkpoint Inhibition: New Therapeutic Approaches...
Read MorePosted by Daniel P. Petrylak, MD | May 2017
Dr. Daniel P. Petrylak presented “Checkpoint Inhibitors” at the International...
Read MorePosted by Daniel P. Petrylak, MD | Apr 2017
Dr. Daniel P. Petrylak presented “Update on Radiopharmaceuticals: Choosing a Companion Drug...
Read MorePosted by Daniel P. Petrylak, MD | Apr 2017
Dr. Daniel P. Petrylak presented “Novel Biomarker-Guided Treatment: PSMA, PAR, HDACs,...
Read MorePosted by Daniel P. Petrylak, MD | Apr 2017
Dr. Daniel P. Petrylak and Dr. Michael S. Cookson presented “Point-Counterpoint: Early...
Read More